Trends in anemia at initiation of dialysis in the United States

Kidney International

Volumn 60, Issue 5, 2001, Pages 1875-1884

  Obrador, Gregorio T ^a,b,c,d   Roberts, Tricia ^a,b,c,d   St Peter, Wendy L ^a,b,c,d   Frazier, Eric ^a,b,c,d   Pereira, Brian J G ^a,b,c,d   Collins, Allan J ^a,b,c,d  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSIDAD PANAMERICANA   (Mexico)

^c Nephrology Analytical Services   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Chronic renal insufficiency; Endstage renal disease; Erythropoietin; Hematocrit; Hemodialysis; Left ventricular hypertrophy

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADOLESCENT; ADULT; AGE; AGED; ANEMIA; ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; GEOGRAPHIC DISTRIBUTION; HEALTH CARE MANAGEMENT; HEMATOCRIT; HEMODIALYSIS; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NEWBORN; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; TREATMENT OUTCOME; UNITED STATES;

EID: 0034778373     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.00002.x     Document Type: Article

References (30)

1. Clinical epidemiology of cardiovascular disease in chronic renal failure
2. Erythropoietin
3. Cardiovascular effects of recombinant human erythropoietin in predialysis patients
4. Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy
5. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure
6. The long-term effects of recombinant human erythropoietin on the cardiovascular system
7. Prevalence of and factors associated with sub-optimal care prior to initiation of dialysis in the United States
8. Application of a weighted head-banding algorithm to mortality data maps
9. NKF-DOQI Clinical Practice Guidelines for the treatment of anemia of chronic renal failure
10. European best practice guidelines for the management of anemia in patients with chronic renal failure
11. Clinical practice guidelines of the Canadian Society of Nephrology for treatment of patients with chronic renal failure
12. Anemia management in patients with chronic renal insufficiency
13. The referral pattern of patients with ESRD is a determinant in the choice of dialysis modality
14. Prevalence, predictors and consequences of late nephrology referral at a tertiary care center
15. Leukopenia, neutropenia and reduced hemoglobin levels in healthy American blacks
16. Gender discrepancies in living related renal transplant donors and recipients
17. Racial differences in the delivery of hemodialysis
18. Ethnic differences in the use of peritoneal dialysis as initial treatment for end-stage renal disease
19. Use of cardiovascular procedures among black persons and white persons: A 7-year nationwide study in patients with renal disease
20. Gender and ethnic differences in hospital-based procedure utilization in California
21. Late initiation of dialysis among women and ethnic minorities in the United States
22. Predictors of type of vascular access in hemodialysis patients
23. Relationship between hematocrit and renal function in men and women
24. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
25. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
26. Impact of left ventricular hypertrophy on survival in end-stage renal disease
27. Hematocrit levels and hospitalization risk in hemodialysis patients
28. Hematocrit level and associated mortality in hemodialysis patients
29. Use of erythropoietin before the initiation of dialysis and its impact on mortality